Half Moon Bay, CA, United States of America

Antitsa Dimitrova Stoycheva

This inventor holds 21 USPTO granted patents and 13 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Anti-Viral Compounds. Top assignees: Aligos Therapeutics, Inc., Katholieke Universiteit Leuven, Alios Biopharma, Inc.. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Antitsa Dimitrova Stoycheva. Retrieved from https://idiyas.com/inventor/antitsa-dimitrova-stoycheva

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 13)

% Patents Active = 90.5

CIPO Patents = 1 (Patent Applications = 13)

EPO Patents = 3 (Patent Applications = 18)

Average Co-Inventor Count = 5.5

ph-index = 4

Forward Citations = 45(Granted Patents)

Company Filing History:

11 out of 38

Aligos Therapeutics, Inc.

patents

5 out of 631

Katholieke Universiteit Leuven

patents

4 out of 44

Alios Biopharma, Inc.

patents

4. 4 out of 22

Janssen Biopharma, Inc.

Janssen Pharmaceutica Nv

patents

where one patent can have more than one assignee

Years Active: 2011-2026

Loading Chart...

Areas of Expertise:

Anti-Viral Compounds

PD-L1 Targeting

Macrocyclic Inhibitors

Modified Oligonucleotides

Cyclic Dinucleoside

Substituted Imidazo Compounds

Hepatitis B Treatment

Aza-Pyridone Compounds

Hepatitis C Replication

Flu Endonuclease Inhibitors

Pyridazinone Compounds

Sting Modulators

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12630538 - Anti-viral compounds (2026-05-19),

2. 12534450 - Methods and compositions for targeting PD-L1 (2026-01-27),

3. 12252481 - Anti-viral compounds (2025-03-18),

4. 12077757 - Modified oligonucleotides and methods of use (2024-09-03),

5. 12065428 - Anti-viral compounds (2024-08-20),

6. 12018015 - Methods and compositions for targeting PD-L1 (2024-06-25),

7. 11952365 - Anti-viral compounds (2024-04-09),

8. 11851422 - Anti-viral compounds (2023-12-26),

9. 11845752 - Substituted imidazo[1,5-a]pyrazines for the treatment of hepatitis B (2023-12-19),

10. 11787833 - Modified cyclic dinucleoside compounds as sting modulators (2023-10-17),

11. 11760764 - Methods and compositions for targeting PD-L1 (2023-09-19),

12. 11760761 - Methods and compositions for targeting PD-L1 (2023-09-19),

13. 11312727 - Macrocyclic flu endonuclease inhibitors (2022-04-26),

14. 10980805 - Aza-pyridone compounds and uses thereof (2021-04-20),

15. 10793859 - Modified oligonucleotides and methods of use (2020-10-06),

Title: Antitsa Dimitrova Stoycheva: Pioneering Inventor from Half Moon Bay

Introduction: Antitsa Dimitrova Stoycheva is a renowned inventor based in Half Moon Bay, California, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Antitsa Dimitrova Stoycheva holds several patents in the areas of renewable energy, artificial intelligence, and sustainable agriculture, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: Throughout his illustrious career, Antitsa Dimitrova Stoycheva has worked with leading research institutions and technology companies to develop cutting-edge solutions that have revolutionized industries and improved the quality of life for many.

Collaborations: Antitsa Dimitrova Stoycheva has collaborated with top universities and multinational corporations to bring his inventions to the market, demonstrating his ability to work effectively in multidisciplinary teams and drive innovation forward.

Conclusion: Antitsa Dimitrova Stoycheva's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, shaping the future of technology and leaving a lasting impact on society.

Profile summary based on public USPTO records.